Horizon 2020 SME
Scientific Literature

Scientific literature about H-FABP can be downloaded here.

  1. F. C. Glatz and R. Mohren (2013). Plasma reference value of heart-type fatty acid-binding protein, the earliest available plasma biomarker of acute myocardial infarction.
    Health Vol.5, No.8, 1206-1209 (2013)
  1. Buntinx F (2013). New markers in suspected acute coronary syndromes: are they relevant for primary care?
    Poster Presentation. 6th Annual Scientific Meeting of the European Primary Care Cardiovascular Society (EPCCS), September 2013, London, UK
  1. Willensen R, Dinant G-J, Buntinx F, Glatz J et al (2013). Heart-type Fatty Acid Binding Protein compared to high-sensitive Troponin T for early exclusion of acute myocardial infarction.
    Poster Presentation. 6th Annual Scientific Meeting of the European Primary Care Cardiovascular Society (EPCCS), September 2013, London, UK
  1. Glatz JFC, Van Bilsen M, Paulussen RJ, et al (1988). Release of fatty acid binding protein from isolated rat heart subjected to ischaemia and reperfusion or to the calcium paradox.
    Biochem. Biophys. Acta. 961, 148-152.
  1. Thygesen K, Alpert JS, Jaffe AS, et al (2012). Third universal definition of myocardial infarction.
    European Heart Journal 33, 2551–2567
  1. Body R, Carley S, McDowell G, et al. (2014) The Manchester Acute Coronary Syndromes (MACS) decision rule for suspected cardiac chest pain: derivation and external validation. Heart 100, 1462-1468.
  1. Glatz JFC and Renneberg R (2014). Added value of H-FABP as a biomarker for the early evaluation of suspected acute coronary syndrome.
    Clin Lipidol. 9 (2), 205-220
  1. Willemsen RTA, Severen EV, Vandervoort PM et al (2015). Heart-type fatty acid binding protein (H-FABP) in patients in an emergency department setting, suspected of acute coronary syndrome: Optimal cut-off point, diagnostic value and future opportunities in primary care.
    Eur J Gen Pract. Published Early Online DOI: 10.3109/13814788.2015.1013934
  1. H-FABP True Rapid Test®: A Novel Point of Care IVD to Aid Effective Risk Stratification for AMI within 4 hours of Symptom Onset. Jan FC Glatz & Richard Body (2015). Pan European Networks: Science & Technology 16.
    132-134. ISSN:2049-2405 (Online).